校正：白藜芦醇和血管生成素-2联合PEGDA/TCS水凝胶通过激活自噬途径靶向治疗缺氧性骨缺损。

IF 4.8 2区医学 Q1 PHARMACOLOGY & PHARMACY

Frontiers in Pharmacology Pub Date : 2025-09-17 eCollection Date: 2025-01-01 DOI:10.3389/fphar.2025.1597755

Dehui Fan, Hengping Liu, Zhenning Zhang, Meiyi Su, Zhixian Yuan, Ying Lin, Shuquan Yang, Wenqiang Li, Xintao Zhang

引用次数: 0

摘要

[这更正了文章DOI: 10.3389/fphar.2021.618724.]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: Resveratrol and Angiogenin-2 combined with PEGDA/TCS hydrogel for the targeted therapy of hypoxic bone defects via activation of the autophagy pathway.

[This corrects the article DOI: 10.3389/fphar.2021.618724.].

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Frontiers in Pharmacology PHARMACOLOGY & PHARMACY-

CiteScore

7.80

自引率

8.90%

发文量

5163

审稿时长

14 weeks

期刊介绍： Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.